查尔斯河将关闭细胞疗法CDMO基地,裁员20名员工。
Charles River to close cell therapy CDMO site, lay off 20 staffers
生物技术与制药领域的最新动态
Charles River to close cell therapy CDMO site, lay off 20 staffers
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment
Building a robust in-process testing plan for cell therapy manufacturing success
Single-nucleus transcriptional and chromatin accessibility analyses of maturing mouse Achilles tendon uncover the molecular landscape of tendon stem/progenitor cells
Molecular features of human pathological tau distinguish tauopathy-associated dementias
Human orbitofrontal neural activity is linked to obsessive-compulsive behavioral dynamics
Sympathetic-epithelial crosstalk governs tissue-resident memory T cell immunosurveillance in the skin
Hallmarks of cancer—Then and now, and beyond
Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo
Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature
Mechanistic insights into RNA chaperoning by Ro60 and La autoantigens
A Bacteroides synthetic biology toolkit to build an in vivo malabsorption biosensor
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
A non-catalytic role for RFC in PCNA-mediated processive DNA synthesis
AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
Single-cell transcriptomics identifies altered neutrophil dynamics and accentuated T-cell cytotoxicity in tobacco-flavored e-cigarette-exposed mouse lungs
A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator
Field-effect-informed urine liquid biopsy for bladder cancer
AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy
An uORF-encoded mobile peptide sparks systemic stomatal immunity